SPINEART today announced that it has completed over 1,000 JULIET Ti-LIFE procedures in the US. Ti-LIFETECHNOLOGY is an enhanced algorithm for additive manufacturing resulting in a porous structure that mimics trabecular bone. Ti-LIFE structure has an average pore diameter and overall porosity similar to trabecular bone, which may enable cell colonization and promote bone in-growth. Ti-LIFE technology allows the production of implants with reduced overall density, optimizing intra and post-operative visualization. Testing has shown Ti-LifeTECHNOLOGY has a lower Modulus of Elasticity when compared to PEEK material, as well as lower risk of subsidence and superior compressive strength vs. PEEK cages. TiLife TECHNOLOGY is expected to be one of the company’s main growth generators in the coming years as it becomes integrated into additional product lines.
About TI-LIFE TECHNOLOGY
TI-LIFE TECHNOLOGY replicates the trabecular bone to support cell adhesion and bone in-growth. This patented technology is based on a revolutionary algorithm associated with a state-of-the-art additive manufacturing process.
About SPINEART
Spineart is a privately held medical device company focused on simplifying the surgical act by designing, developing and promoting safe and efficient solutions to spine surgeons, operating room teams, and patients. The company was established in 2005 and is currently operating in 46 countries worldwide.Spineart is a pioneer in its field, having introduced unique patented and clinically validated technologies in the fields of Minimally Invasive Surgery, Motion Preservation, Fusion, Biologics, and Fractures Treatment.Spineart markets a complete portfolio combining traceable barcoded sterile packed implants with compact instrument sets, thus proudly promoting greater safety, cost-efficiency, and compliance at the hospital. Please visit:http://www.spineart.com